NiKang Therapeutics logo

NiKang Therapeutics

Investments
1
Lead Investments
0

NiKang Therapeutics is a clinical-stage biotech company focused on discovering and developing innovative small molecule oncology medicines. Established in 2017, the company employs target structural biology and structure-based drug design to create novel treatments for cancer.

Founded 2017
North America, United States
11-50
nikangtx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Oncology

Notable Investments

NiKang Therapeutics logo

Investment History

Team